FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy
Related Topics >> India | counterfeiting

India reports change in fakes-distribution tactic

Free Newsletter

FiercePharma Manufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Sign up today to receive your FREE "insiders only" weekly pharma manufacturing industry briefing.



Tools

Racketeers have changed the game in India, delivering small quantities of counterfeit drugs to avoid seizure and conceal both source and supply route. The practice contrasts with more common bulk consignments, in which carriers pick up quantities from sites that make the fakes but entire shipments are vulnerable to seizure if detected.

The new method makes it difficult for investigators to find the source of supply, reports the Times of India. Those caught carrying the fakes know only the person who supplies them, rather than the actual source.

Police last week arrested one person and recovered 7,500 tablets of blood-pressure medication Listril and 60 units of hemorrhage drug Octride-100. Their packaging displays phony trademarks. Officials say the market value of the recovered medicines is about $1,600.

Cardiovascular treatments are among the most often counterfeit of drugs.

- see the article

Related Articles:
Chinese made-in-India fakes seized by regulators
India steps up control of imports
India seeks anti-fakes tools to preserve reputation


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:

More stories about India   counterfeiting